Axon Enterprise, Inc. (AXON) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with a 25% revenue increase and improved gross margins. Net income and operating cash flow also showed significant growth. Despite acknowledging risks, the financial metrics suggest robust operational health. The lack of details on strategic initiatives and returns limits a stronger positive outlook, but the financial improvements suggest a positive stock price movement.
Key Financial Performance
Revenue Axon reported revenue of $500 million for Q1 2026, representing a 25% year-over-year increase. This growth was driven by strong demand for its TASER devices and software solutions.
Gross Margin The gross margin for the quarter was 65%, up from 62% in Q1 2025. The improvement was attributed to operational efficiencies and a favorable product mix.
Net Income Net income for Q1 2026 was $50 million, a 10% increase compared to the same period last year. This was due to higher revenue and controlled operating expenses.
Operating Cash Flow Operating cash flow came in at $120 million, up 15% year-over-year, supported by improved collections and operational performance.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks are not specified but are acknowledged as potential challenges to achieving projected outcomes.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Alexander Latimore
Blair LLC
Brenden Rogers
Brittany Bagley
CFO Jeffrey
CTO Power
Capital Markets
Co Research
Director Brittany
Division Alexander
Division Cardoso
Division Fish
Division Jeremy
Division Jonathan
Division Jordan
Division Keith
Division PM
Division Paige
Division Trevor
Erik Lapinski
Group
Ho Blair
Jeremy Hamblin
Jonathan Ho
Jordan Lyonnais
Keith Housum
LLC Brenden
LLC Research
Markets Research
PM EDT
Paige Papadogonas
Research Division
AXON Transcript
Axon Enterprise, Inc. (AXON) Q1 2026 Earnings Call Transcript
Positive5-6
The earnings call reveals strong financial performance with a 25% revenue increase and improved gross margins. Net income and operating cash flow also showed significant growth. Despite acknowledging risks, the financial metrics suggest robust operational health. The lack of details on strategic initiatives and returns limits a stronger positive outlook, but the financial improvements suggest a positive stock price movement.
Axon Enterprise, Inc. (AXON) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Neutral3-3
Axon Enterprise, Inc. (AXON) Q4 2025 Earnings Call Transcript
Positive2-25
The earnings call summary and Q&A session highlight strong financial performance with a 31% revenue growth forecast and a 46% increase in adjusted EBITDA. Despite tariff impacts, the company maintains a 25% EBITDA margin target. Positive factors include strategic investments in AI and international expansion, a record 9-figure cloud deal, and confidence in future growth. While specific guidance was avoided, optimism in demand and market traction was evident. These elements suggest a positive stock price movement over the next two weeks.
Axon Enterprise, Inc. (AXON) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call summary and Q&A reveal a positive outlook with raised revenue and EBITDA guidance, strong product development, and international expansion. The Q&A section highlighted analysts' positive sentiment towards international deals and growth in various segments, including software and services. Despite some concerns about competition and tariffs, the overall sentiment remains positive, supported by strong bookings growth and strategic investments. The raised guidance and optimistic future outlook suggest a positive stock price reaction over the next two weeks.
AXON Slides
AXON Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
